Preetam Shah

Insider Reports History

Entity
Individual
Location
C/O Brainstorm Cell Therapeutics, Inc., 1325 Avenue Of Americas, 28 Th Flr., New York, NY
Signature
/s/ Shane Ward, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Preetam Shah:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cidara Therapeutics, Inc. CFO & CBO Common Stock 336K $232K $0.69 Mar 15, 2024 Direct
Cidara Therapeutics, Inc. CFO & CBO Employee Stock Option (right to buy) 218K Mar 15, 2024 Direct

Insider Reports Filed by Preetam Shah

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CDTX Cidara Therapeutics, Inc. Mar 15, 2024 2 $0 4 Mar 20, 2024 CFO & CBO
CDTX Cidara Therapeutics, Inc. Mar 11, 2024 1 -$12.7K 4 Mar 12, 2024 CFO & CBO
CDTX Cidara Therapeutics, Inc. Mar 27, 2023 2 $0 4 Mar 29, 2023 CFO & CBO
CDTX Cidara Therapeutics, Inc. Mar 13, 2023 1 -$10.2K 4 Mar 13, 2023 CFO & CBO
CDTX Cidara Therapeutics, Inc. Sep 15, 2022 3 -$12K 4 Sep 19, 2022 CFO & CBO
CDTX Cidara Therapeutics, Inc. Mar 31, 2022 4 -$20.6K 4 Apr 4, 2022 CFO & CBO
CDTX Cidara Therapeutics, Inc. Nov 12, 2021 1 $30.8K 4 Nov 15, 2021 CFO & CBO
CDTX Cidara Therapeutics, Inc. Sep 1, 2021 2 $0 4 Sep 3, 2021 CFO & CBO
CDTX Cidara Therapeutics, Inc. Sep 1, 2021 0 $0 3 Sep 3, 2021 CFO & CBO